Meral UYAR, Alper SEVİNÇ, Lütfiye PİRBUDAK, Elzem ŞEN

Characteristics of pain in lung cancer patients

Amaç: Bu çalışmada primer akciğer kanserli hastalarda ağrının özellikleri değerlendirildi. Çalışma planı: Ocak 2004 - Ocak 2009 tarihleri arasında Gaziantep Üniversitesi Tıp Fakültesi Algoloji kliniğine başvuran 216 primer akciğer kanserli hastanın (184 erkek, 32 kadın; ort. yaş 63 yıl; dağılım 30-85 yıl) verileri retrospektif olarak değerlendirildi. Kanserle ilişkili ağrının başlangıcı, yeri ve doğası değerlendirildi. Bulgular: Ağrı sırt, omuz, üst karın, sakroiliyakeklem ve bacaklarda yerleşmiş idi. Çalışma grubunda, ağrı 154 hastada (%71.3) akciğer dışı metastaz, 62 hastada (%28.7) ise akciğerdeki primer tümördenkaynaklanmakta idi. Yüz beş hastada (%48.6) nöropatik ağrı, 61 hastada (%28.2) ise viseral ağrı vardı. Viseral ve nöropatik ağrının ortalama başlama zamanı sırasıyla 2 ve 12 hafta idi. Tıbbi tedavi hastaların %68.5’de etkili bulundu. Ancak hastaların %31.5’de tıbbi tedaviye ek olarak santral ve periferik bloklar ile ağrı kontrol edildi. Sonuç: Çalışma bulgularımız, nöropatik ağrının çalışmagrubunda daha sık görüldüğünü ve ağrının tüm hastalardatıbbi veya girişimsel yöntemler ile kontrol altına alındığınıgösterdi.

Akciğer kanserli hastalarda ağrının özellikleri

Background: This study aims to evaluate characteristicsof pain in primary lung cancer patients.Methods: Between January 2004 and January 2009, dataof 216 patients with primary lung cancer (184 males,32 females, mean age 63 years; range 30 to 85 years)who were admitted to Gaziantep University, Faculty ofMedicine, Algology Outpatient Clinic were retrospectivelyanalyzed. The onset, localization and nature of cancer-related pain were evaluated.Results: Pain was localized in the back, shoulders, upperabdomen, sacroiliac joint and legs. Pain originated fromnon-pulmonary metastasis in 154 patients (71.3%) andprimary lung cancer in 62 patients (28.7%) in the studygroup. One hundred five (48.6%) patients had neuropathicpain, while 61 patients had visceral pain (28.2%). Themean onset of visceral and neuropathic pain was 2 and 12weeks, respectively. Medical treatment was found to beeffective in 68.5% patients. However, pain was controlledwith central or peripheral block in addition to medicaltreatment in 31.5% patients.Conclusion: Our study results showed that neuropathicpain was more frequent in the population and pain wascontrolled with medical or interventional methods in allpatients.

PDF

___

1. Montgomery F. Palliative care managing chronic cancer pain. Hospital Pharmacist 2001;8:215-8.
2. Kuzeyli Yildirim Y, Uyar M. Barriers to effective cancer pain management. [Article in Turkish] Agri 2006;18:12-9.
3. Simone CB 2nd, Vapiwala N, Hampshire MK, Metz JM. Cancer patient attitudes toward analgesic usage and pain intervention. Clin J Pain 2012;28:157-62.
4. O’Neill B, Fallon M. ABC of palliative care. Principles of palliative care and pain control. BMJ 1997;315:801-4.
5. Kvale PA, Simoff M, Prakash UB; American College of Chest Physicians. Lung cancer. Palliative care. Chest 2003;123:284S-311S.
6. Rhodes DJ, Koshy RC, Waterfield WC, Wu AW, Grossman SA. Feasibility of quantitative pain assessment in outpatient oncology practice. J Clin Oncol 2001;19:501-8.
7. Reyes-Gibby CC, Anderson KO, Shete S, Bruera E, Yennurajalingam S. Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non- Hispanic blacks. Cancer 2012;118:856-63.
8. Orhan ME, Bilgin F, Ergin A, Dere K, Güzeldemir ME. Pain treatment practice according to the WHO analgesic ladder in cancer patients: eight years experience of a single center. [Article in Turkish] Agri 2008;20:37-43.
9. Kocoglu H, Pirbudak L, Pence S, Balat O. Cancer pain, pathophysiology, characteristics and syndromes. Eur J Gynaecol Oncol 2002;23:527-32.
10. Pardon K, Deschepper R, Vander Stichele R, Bernheim JL, Mortier F, Bossuyt N, et al. Changing preferences for information and participation in the last phase of life: a longitudinal study among newly diagnosed advanced lung cancer patients. Support Care Cancer 2012;20:2473-82.
11. Fitzgibbon DR. Mechanisms, assessment, and diagnosis of pain due to cancer. In: Fishman SM, Ballantyne JC, Rathmell JP, editors. Bonica’s management of pain. 4th ed. Philadelphia: Lippincott Williams & Wilkinss; 2010. p. 559-82.
12. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
13. The World Health Organization's Fight against Cancer: Strategies That Prevent, Cure and Care. World Health Organization. Available from: http://www.who.org.
14. Banning A, Sjøgren P, Henriksen H. Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain 1991;45:45-8.
15. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249:9-17.
16. Lucas LK, Lipman AG. Recent advances in pharmacotherapy for cancer pain management. Cancer Pract 2002;10 Suppl 1:S14-20.
17. Potter J, Higginson IJ. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer 2004;43:247-57.
18. Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, Tu W. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA 2010;304:163-71.
19. Reale C, Turkiewicz AM, Reale CA. Antalgic treatment of pain associated with bone metastases. Crit Rev Oncol Hematol 2001;37:1-11.
20. Portenoy RK. Adjuvant analgesics in pain management. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine. 2nd ed. Oxford: Oxford University
21. Twycross R, Sykes N, Mihalyo M, Wilcock A. Stimulant laxatives and opioid-induced constipation. J Pain Symptom Manage 2012;43:306-13.
22. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993;119:121-6.
23. Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study of cancer pain and its treatment in France. BMJ 1995;310:1034-7.
24. Jacox A, Carr DB, Payne R. New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Pres. pp. 361-90. 1998. Med 1994;330:651-5.
25. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al . Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330:592-6.
26. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. High prevalence of pain in patients with cancer in a large population-based study in The Netherlands. Pain 2007;132:312-20.
27. Rustøen T, Fosså SD, Skarstein J, Moum T. The impact of demographic and disease-specific variables on pain in cancer patients. J Pain Symptom Manage 2003;26:696-704.